Aktis Oncology, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 64.2% | 74.2% | 108.4% | 105.7% | 70.7% | 114.4% | 126.1% | 29.4% | 61.9% | 151.9% | 59.8% | 293.4% | 259.3% | 198.9% | 118.1% | 158.9% | 155.4% | 123.9% | 116.6% | 128.1% | 115.9% | 89.9% | 115.2% | 120.4% | 115.5% | 90.3% | 95.4% | 52.3% | – | – | – | – | – | 20.2% | 26.0% | – | |
| – | – | – | 100.0% | 100.0% | 35.8% | 25.8% | -8.4% | -5.7% | 29.3% | -14.4% | -26.1% | 70.6% | 38.1% | -51.9% | 40.2% | -193.4% | -159.3% | -98.9% | -18.1% | -58.9% | -55.4% | -23.9% | -16.6% | -28.1% | -15.9% | 10.1% | -15.2% | -20.4% | -15.5% | 9.7% | 4.6% | 47.7% | 100.0% | – | – | 100.0% | 100.0% | 79.8% | 74.0% | 84.8% | |
| – | – | – | 8,014.7% | 74,475.6% | 998.3% | 781.2% | 1,070.6% | 2,104.1% | 2,164.7% | 1,398.9% | 2,336.1% | 702.8% | 935.4% | 945.4% | 1,589.3% | 1,307.9% | 1,003.1% | 425.5% | 207.6% | 320.1% | 426.9% | 250.3% | 180.5% | 196.5% | 181.4% | 130.3% | 99.9% | 98.0% | 147.8% | 91.4% | 79.5% | 29.8% | 1,351.1% | 1,096.3% | 1,163.5% | 1,042.9% | 882.0% | 620.9% | 747.0% | 778.1% | |
| – | – | – | 8,301.0% | 60,293.5% | 609.0% | 492.6% | 858.6% | 1,314.6% | 1,208.3% | 552.4% | 1,036.1% | 294.0% | 515.8% | 532.6% | 713.2% | 746.7% | 460.2% | 257.0% | 134.9% | 167.0% | 207.5% | 140.1% | 124.2% | 114.7% | 125.4% | 99.5% | 119.9% | 96.7% | 146.0% | 132.4% | 119.0% | 76.9% | 422.4% | 231.2% | 229.9% | 193.9% | 134.2% | 165.5% | 189.2% | 172.1% | |
| – | – | – | 14,284.9% | 134,119.8% | 1,607.3% | 1,273.8% | 1,929.3% | 3,418.8% | 3,319.2% | 1,951.3% | 3,372.2% | 1,013.0% | 1,451.2% | 1,478.0% | 2,302.5% | 2,054.6% | 1,463.4% | 682.5% | 342.5% | 487.1% | 634.4% | 390.5% | 304.6% | 311.2% | 306.8% | 229.9% | 219.8% | 194.7% | 293.8% | 223.8% | 210.3% | 106.8% | 1,775.8% | 1,353.8% | 1,409.4% | 1,252.8% | 1,029.1% | 783.4% | 928.0% | 951.4% | |
| – | – | – | -14,184.9% | -134,019.8% | -1,571.5% | -1,248.0% | -1,937.6% | -3,646.5% | -3,289.9% | -1,965.7% | -3,398.3% | -949.8% | -1,413.1% | -1,529.9% | -2,262.3% | -2,248.1% | -1,622.6% | -781.4% | -360.6% | -546.0% | -689.7% | -414.4% | -321.2% | -339.3% | -322.8% | -219.8% | -234.9% | -215.2% | -309.3% | -214.1% | -301.0% | -59.1% | -1,675.8% | -1,253.8% | -1,309.4% | -1,152.8% | -929.1% | -703.6% | -854.0% | -866.6% | |
| – | – | – | – | – | – | – | – | 185.7% | 236.6% | – | – | 129.6% | 183.1% | 212.7% | 320.1% | 359.0% | 225.0% | 130.2% | 80.5% | – | – | – | – | 3.2% | 13.3% | 12.0% | 6.9% | 4.4% | 6.9% | 9.7% | 9.9% | 7.9% | – | – | – | – | – | – | – | – | |
| – | – | – | -14,235.7% | -63,936.8% | -1,542.9% | -1,246.3% | -1,688.6% | -3,794.2% | -3,590.1% | -2,086.6% | -3,972.8% | -848.8% | -1,652.9% | -1,798.1% | -2,141.6% | -2,753.3% | -1,878.9% | -910.6% | -404.3% | -469.2% | -687.8% | -413.6% | -324.6% | -346.6% | -344.0% | -190.2% | -243.5% | -213.5% | -287.5% | -223.9% | -310.3% | -71.1% | -1,292.2% | -1,035.6% | -1,129.0% | -983.7% | -809.5% | -567.9% | -713.5% | -727.0% | |
| – | – | – | 106.1% | – | – | -1.8% | – | – | – | 16.3% | – | – | – | – | – | – | – | – | – | – | – | 1.6% | -2.8% | -33.9% | -1.0% | 0.0% | -32.1% | -0.3% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | -14,235.7% | -63,936.8% | -1,542.9% | -1,246.3% | -1,688.6% | -3,794.2% | -3,590.1% | -2,086.6% | -3,972.8% | -848.8% | -1,652.9% | -1,798.1% | -2,141.6% | -2,753.3% | -1,878.9% | -910.6% | -404.3% | -469.2% | -687.8% | -415.7% | -321.8% | -312.7% | -343.0% | -190.2% | -211.3% | -213.2% | -287.5% | -223.9% | -310.4% | -71.1% | -1,292.2% | -1,035.6% | -1,129.0% | -983.7% | -809.5% | -567.9% | -713.5% | -727.0% | |
| – | – | – | -13,926.4% | -137,818.5% | -1,492.7% | -1,193.8% | -1,825.9% | -3,162.4% | -3,008.6% | -1,775.9% | -3,134.0% | -841.8% | -1,336.8% | -1,390.2% | -2,048.8% | -2,006.0% | -1,458.0% | -693.0% | -310.4% | -479.6% | -605.7% | -365.4% | -265.4% | -306.9% | -277.0% | -173.5% | -191.3% | -171.0% | -264.6% | -166.8% | -255.5% | -44.5% | -1,244.9% | – | -1,274.9% | -1,114.9% | -772.4% | -547.7% | -828.0% | -772.8% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.